Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omeprazole.

Literature DB >> 1680515

Omeprazole.

M J Langman.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1991 PMID： 1680515 PMCID： PMC1670828 DOI： 10.1136/bmj.303.6801.481

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

19 in total

1. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia.

Authors: K Borch; H Renvall; G Liedberg
Journal: Gastroenterology Date: 1985-03 Impact factor: 22.682

2. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.

Authors: S Lanzon-Miller; R E Pounder; M R Hamilton; S Ball; N A Chronos; F Raymond; M Olausson; C Cederberg
Journal: Aliment Pharmacol Ther Date: 1987-06 Impact factor: 8.171

3. Cell digestion and genotoxicity assessment in gastric mucosa.

Authors: G Sachs; D Scott
Journal: Digestion Date: 1990 Impact factor: 3.216

4. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.

Authors: S Sandmark; R Carlsson; O Fausa; L Lundell
Journal: Scand J Gastroenterol Date: 1988-06 Impact factor: 2.423

5. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

Authors: D Poynter; C R Pick; R A Harcourt; S A Selway; G Ainge; I W Harman; N W Spurling; P A Fluck; J L Cook
Journal: Gut Date: 1985-12 Impact factor: 23.059

6. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.

Authors: K D Bardhan; G Bianchi Porro; K Bose; M Daly; R F Hinchliffe; E Jonsson; M Lazzaroni; J Naesdal; L Rikner; A Walan
Journal: J Clin Gastroenterol Date: 1986-08 Impact factor: 3.062

7. Effect of bicarbonate, acetate, and citrate on water and sodium movement in normal and cholera toxin-treated rat small intestine.

Authors: D D Rolston; M J Kelly; M M Borodo; A M Dawson; M J Farthing
Journal: Scand J Gastroenterol Date: 1989-01 Impact factor: 2.423

8. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

Authors: L Lundell; L Backman; P Ekström; L H Enander; O Fausa; T Lind; H Lönroth; S Sandmark; B Sandzén; P Unge
Journal: Aliment Pharmacol Ther Date: 1990-04 Impact factor: 8.171

Omeprazole.

1. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia.

2. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.

3. Cell digestion and genotoxicity assessment in gastric mucosa.

4. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.

5. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

6. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.

7. Effect of bicarbonate, acetate, and citrate on water and sodium movement in normal and cholera toxin-treated rat small intestine.

8. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

9. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.

10. Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study.

1. Omeprazole.

2. Omeprazole.

Review 3. Acid suppression and claims of genotoxicity. What have we learned?

Review 4. A comparative overview of the adverse effects of antiulcer drugs.